© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Orchestra BioMed Holdings, Inc. (OBIO) shows an Average True Range (ATR) of 0.29 and an Enterprise Value of 131.41M. Its average trading volume over the past 3 months is 209.11K, indicating liquidity. These fundamental metrics provide insight into OBIO's underlying financial health and market activity.
| ATR | 0.29 |
| Enterprise Value | 131.41M |
| Avg Vol (3 Months) | 209.11K |
| Avg Vol (10 Days) | 261.33K |
Orchestra BioMed Holdings, Inc. (OBIO) technical indicators as of February 26, 2026: the SMA 20 is 10.53%, SMA 50 at 4.32%, and SMA 200 at 25.69%. The RSI 14 value is 58.49, suggesting its current momentum. These technical analysis signals help assess OBIO's price trends and potential future movements.
| SMA 20 | 10.53% |
| SMA 50 | 4.32% |
| SMA 200 | 25.69% |
| RSI 14 | 58.49 |
Orchestra BioMed Holdings, Inc. (OBIO) stock performance overview as of February 26, 2026: The 52-week high is $5.42 (currently -19.8% below), and the 52-week low is $2.2 (currently 97.73% above). Over the past year, OBIO's performance is -25.74%, compared to the S&P 500's 10.91% change.
| 52-Week High | 5.42 |
| 52-Week High Chg | -19.80% |
| 52-Week Low | 2.2 |
| 52-Week Low Chg | +97.73% |
| S&P 500 52-Week Chg | 10.91% |
According to market data, Orchestra BioMed Holdings, Inc. (OBIO) stock's recent performance metrics show that over the last month, OBIO is -6.05%, with a Year-to-Date (YTD) performance of -2.65%. Over the past year, the stock has seen a -25.74% change. These figures summarize OBIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.39 | 4.39 | 5.42 | 5.42 | 5.42 | 5 |
| Low | 3.76 | 3.46 | 3.46 | 2.2 | 2.2 | 3.46 |
| Performance | -13.30% | -6.05% | +21.69% | +27.85% | -25.74% | -2.65% |
According to current financial data, OBIO stock's P/E (TTM) ratio is -2.21, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for OBIO, including P/S (86.66), P/B (3.80), and P/FCF (-4.02), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | OBIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.21 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 86.66 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 3.8 | 0 | 9 | 5.26 |
| P/FCF (TTM) | -4.02 | -6.95 | -253.28 | 30.85 |